The Cialis® New Zealand website is closed

For further information or queries about Cialis in New Zealand, please call Lilly on 0800 500 056

 ®CIALIS and the Cialis logo are registered trademarks of Eli Lilly & Company. This site is intended for use by New Zealand Residents only aged 18 years and over.

Cialis (tadalafil) is an unfunded Prescription Medicine, for which charges will apply. Approved Indication: Erectile dysfunction (ED) in adult men. In order for Cialis to be effective in treating ED sexual stimulation is required. Moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in adult men. Adult men with co-existing ED and LUTS associated with BPH. Dosage and Administration: ED On-Demand Dosing - 10 mg or 20 mg, prior to anticipated sexual activity. Maximum Dose: On-Demand Dosing - 20mg in one day. Effective up to 36 hours after dosing and in some patients as early as 16 minutes after dosing. ED and/or LUTS/BPH Once-A-Day Dosing - 5mg taken once a day at approximately the same time of day. Maximum regular daily dose must not exceed 5mg. Cialis has benefits and risks. Contraindications: Concomitant use with Nitrates, unstable cardiovascular disease, myocardial infarction within the last 90 days, unstable angina or angina, New York Heart Association Class 2 or greater heart failure in the last 6 months, uncontrolled arrhythmias, hypotension (<90/50 mm Hg), or uncontrolled hypertension, stroke within the last 6 months, loss of vision in one eye because of non-arteritic anterior ischaemic optic neuropathy (NAION), hypersensitivity to tadalafil or its excipients, Precautions: Severe renal or hepatic insufficiency, creatinine clearance  50 mL/min, potential cardiac risk of sexual activity in patients with pre-existing cardiovascular disease, prior to initiating treatment for LUTS/BPH patients should be examined to rule out the presence of carcinoma of the prostate, patients who have predisposing conditions for priapism, discontinue if sudden loss of vision in one or both eyes, sudden decrease or loss of hearing. Interactions: combination use with anti-hypertensives, other treatments for erectile dysfunction or non-selective alpha[1] blockers, doxazosin for potentiation of hypotensive effects, CYP 3A4 or HIV protease inhibitors. . Adverse Effects: Very Common ( 10%): dyspepsia, headache. Common ( 1% and < 10%): flushing, back pain, myalgia, pain in extremity, nasal congestion, gastroesophageal reflux disease, diarrhoea, abdominal pain, upper respiratory tract infection. Please review Full Datasheet before Prescribing. Full Datasheet is available on request from Eli Lilly or www.medsafe.govt.nz. Eli Lilly and Co (NZ)Limited, Level 1, 123 Ormiston Rd. Botany South, Auckland Telephone 0800 500 056. Based on Datasheet last amended 31 January 2013. TAPS CH4204. NZCLS00059a(1). November 2014.